Knudten Andrew F. 4
4 · AveXis, Inc. · Filed Mar 5, 2018
Insider Transaction Report
Form 4
AveXis, Inc.AVXS
Knudten Andrew F.
SrVP/Manufacture&Supply Chain
Transactions
- Sale
Common Stock
2018-03-01$126.84/sh−468$59,361→ 5,576 total - Sale
Common Stock
2018-03-01$127.92/sh−421$53,854→ 5,155 total - Sale
Common Stock
2018-03-01$128.70/sh−155$19,949→ 5,000 total - Sale
Common Stock
2018-03-01$124.37/sh−177$22,013→ 6,548 total - Exercise/Conversion
Common Stock
2018-03-01$18.17/sh+2,000$36,340→ 7,000 total - Sale
Common Stock
2018-03-01$123.02/sh−146$17,961→ 6,725 total - Sale
Common Stock
2018-03-01$121.95/sh−129$15,732→ 6,871 total - Sale
Common Stock
2018-03-01$125.74/sh−504$63,373→ 6,044 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-03-01−2,000→ 143,800 totalExercise: $18.17Exp: 2025-08-11→ Common Stock (2,000 underlying)
Footnotes (9)
- [F1]These sales were effected pursuant to a Rule 10b5-1 Sales Plan adopted by the Reporting Person on August 29, 2017.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.50 to $122.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.60 to $123.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.08 to $124.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.19 to $126.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (5) to this Form 4.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.38 to $127.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (6) to this Form 4.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.51 to $128.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (7) to this Form 4.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.63 to $128.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (8) to this Form 4.
- [F9]Immediately exercisable. 37,950 shares vested and became exercisable on August 11, 2016; the remaining shares will vest and become exercisable in 36 equal monthly installments thereafter until August 11, 2019, subject to the Reporting Person's continuous service with the Issuer on each such date.